These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16179095)

  • 21. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
    Heckmayr M
    Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
    Gianni L; Grasselli G
    Suppl Tumori; 2002; 1(4):S60-1. PubMed ID: 12415824
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of lung cancer.
    Stover DE
    Compr Ther; 2003; 29(1):28-34. PubMed ID: 12701340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of lung cancer. The new millennium.
    Kim ES; Hong WK; Khuri FR
    Chest Surg Clin N Am; 2000 Nov; 10(4):663-90, v. PubMed ID: 11091919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.
    Kye SH; Tashkin DP; Roth MD; Adams B; Nie WX; Mao JT
    Contemp Clin Trials; 2009 Sep; 30(5):464-72. PubMed ID: 19508900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of retinoid chemoprevention of lung cancer.
    Benner SE; Lippman SM; Hong WK
    Oncology (Williston Park); 1995 Mar; 9(3):205-10; discussion 210, 213-4, 216. PubMed ID: 7669514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the biology of lung cancer chemoprevention.
    Hirsch FR; Lippman SM
    J Clin Oncol; 2005 May; 23(14):3186-97. PubMed ID: 15886305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-line treatment for advanced non-small-cell lung cancer.
    Laskin JJ; Sandler AB
    Oncology (Williston Park); 2005 Nov; 19(13):1671-6; discussion 1678-80. PubMed ID: 16425521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
    Smith J
    Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.
    Oxnard GR
    Arch Pathol Lab Med; 2012 Oct; 136(10):1205-9. PubMed ID: 23020725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lung cancer - historical development, current status, future prospects].
    Goeckenjan G
    Pneumologie; 2010 Sep; 64(9):555-9. PubMed ID: 20827638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A translational view of the molecular pathogenesis of lung cancer.
    Sato M; Shames DS; Gazdar AF; Minna JD
    J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemoprevention in head and neck cancer and lung cancer].
    Fayette J; Kiakouama L
    Bull Cancer; 2009; 96 Suppl 1():S25-34. PubMed ID: 19433371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
    Raben D; Helfrich B; Bunn PA
    Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemoprevention perspectives for bronchial cancer].
    Scheid P; Vignaud JM; Martinet N; Martinet Y
    Rev Pneumol Clin; 2001 Jun; 57(3):193-9. PubMed ID: 11416802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of low-dose CT on lung cancer screening.
    Diederich S; Wormanns D
    Lung Cancer; 2004 Aug; 45 Suppl 2():S13-9. PubMed ID: 15552777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer.
    Al Olayan A; Al Hussaini H; Jazieh AR
    J Infect Public Health; 2012 Dec; 5 Suppl 1():S50-60. PubMed ID: 23244189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT lung cancer screening in the UK.
    Edey AJ; Hansell DM
    Br J Radiol; 2009 Jul; 82(979):529-31. PubMed ID: 19541944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current usage of molecular targeting drugs].
    Sugio K
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1459-62. PubMed ID: 20860096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.